Joel Baglole

Joel Baglole

Joel Baglole has been a financial reporter for more than 20 years. For five years, Mr. Baglole was a staff reporter at The Wall Street Journal, where he wrote articles from Iceland to Indonesia and covered topics ranging from the automotive and airline industries to investment banks and global stock markets.

Mr. Baglole has also worked for The Washington Post and Toronto Star newspapers, and has contributed to business focused websites such as The Motley Fool and Investopedia. At InvestorPlace, he covers a wide range of large and small cap stocks, as well as political and economic issues that impact financial markets.

Check out Joel’s TipRanks profile.

Recent Articles

CLOV Stock Alert: There’s a $300M Reason Clover Health Is Stumbling Today

Meme stock favorite Clover Health is under pressure today after announcing a new secondary stock offering that has upset investors.

Novavax Stock Looks To Be In Recovery Mode

Novavax is finally healing after months of being beaten down. Is this the start of a big rally or a fragile recovery for NVAX stock?

Bitcoin Should Scale New Heights With Help From the Taproot Upgrade

It's been quite a run for the world's largest digital asset over the past few months. After falling to a trough of $29,789.90 on July 19, BTC-USD has rallied 116% to its current price of $64,364.10. As recently as November 8, Bitcoin's price hit an all-time high of $67,582.60.

DiDi Is Surrounded by Too Much Uncertainty

Chinese ride hailing company DiDi continues to operate under a cloud of uncertainty as regulators loom. Avoid DIDI stock for now.

The Turnaround of IBM Stock Has Yet To Begin

IBM recently split into two publicly traded companies, but even that major milestone has not been enough to turn around its share price.